Your session is about to expire
← Back to Search
Robotic Surgery
Robot-Assisted Surgery for Surgical Procedures
Phase 2
Waitlist Available
Led By Mehdi Moslemi-Kebria
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days of operation
Awards & highlights
Study Summary
This trial tested a robotic device that may allow for less invasive surgeries, reducing pain, complications, and speeding recovery.
Who is the study for?
This trial is for adults over 18 who are scheduled for robot-assisted abdominal or pelvic surgery and have consented to participate. It's not suitable for individuals with a BMI over 45, those who've had unsuccessful minimally invasive surgeries before, or have conditions that make such surgeries risky like severe lung disorders.Check my eligibility
What is being tested?
The study is testing the da Vinci SP1098 robotic device in performing less invasive abdominal and pelvic surgeries through a single small incision. The goal is to see if it leads to less pain, fewer complications, and faster recovery compared to traditional methods.See study design
What are the potential side effects?
While specific side effects aren't listed, typical risks of robot-assisted surgery may include infection at the incision site, bleeding, potential injury to surrounding organs or tissues during operation, and reactions related to anesthesia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 30 days of operation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days of operation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Conversion of operation to laparotomy
Incidence of major surgical complications
Trial Design
1Treatment groups
Experimental Treatment
Group I: Device feasibility (da Vinci SP1098 robotic system)Experimental Treatment1 Intervention
Patients undergo surgery using the da Vinci SP1098 robotic system on study.
Find a Location
Who is running the clinical trial?
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,427 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,120 Total Patients Enrolled
Mehdi Moslemi-KebriaPrincipal InvestigatorCity of Hope Comprehensive Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had previous abdominal or pelvic surgery that was not minimally invasive and was unsuccessful.You have a lung condition called chronic obstructive pulmonary disorder that makes minimally invasive surgery unsafe for you.
Research Study Groups:
This trial has the following groups:- Group 1: Device feasibility (da Vinci SP1098 robotic system)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Can individuals still join this clinical experiment?
"Clinicaltrials.gov indicates that this trial is not currently enrolling patients, as the last update was made on January 3rd 2023. Nonetheless, 890 other trials are actively seeking out participants at this time."
Answered by AI
To what degree is the da Vinci SP1098 robotic system a risk to human health?
"According to our Power team, the safety of Device feasibility (da Vinci SP1098 robotic system) is assessed as 2. This assessment is based on Phase 2 trial data that support its security but lack any confirming evidence for efficacy."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger